Cargando…
Microsatellite Instability and Metastatic Colorectal Cancer – A Clinical Perspective
Approximately 4-5% of patients with metastatic colorectal cancer (mCRC) have mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) tumours. These tumours present challenges in the clinical practice due to variant response to fluoropyrimidine-based chemotherapy and, perhaps, also n...
Autor principal: | Buchler, Tomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097548/ https://www.ncbi.nlm.nih.gov/pubmed/35574322 http://dx.doi.org/10.3389/fonc.2022.888181 |
Ejemplares similares
-
The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives
por: Gandini, Annalice, et al.
Publicado: (2023) -
Toward a Molecular Classification of Colorectal Cancer: The Role of Microsatellite Instability Status
por: Heinimann, Karl
Publicado: (2013) -
Maspin as a Prognostic Marker for Early Stage Colorectal Cancer With Microsatellite Instability
por: Tanaka, Atsushi, et al.
Publicado: (2020) -
Immunotherapy in microsatellite instability metastatic colorectal cancer: Current status and future perspectives
por: Motta, Rodrigo, et al.
Publicado: (2021) -
Mitochondrial microsatellite instability in patients with metastatic colorectal cancer
por: Venderbosch, S., et al.
Publicado: (2015)